{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:16:04Z","timestamp":1761491764047,"version":"3.41.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,28]]},"DOI":"10.7759\/cureus.88945","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T05:53:24Z","timestamp":1753768404000},"source":"Crossref","is-referenced-by-count":1,"title":["Six-Year Remission With No Relapse After Four-Time Weekly Rituximab Only for Bilateral Ocular Adnexal Follicular Lymphoma"],"prefix":"10.7759","author":[{"given":"Toshihiko","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuharu","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.50.27","article-title":"Clonal analysis of bilateral, recurrent, or systemically multifocal ocular adnexal lymphoma","volume":"50","author":"Matsuo T","year":"2010","unstructured":"Matsuo T, Ichimura K, Okada H, et al.. Clonal analysis of bilateral, recurrent, or systemically multifocal ocular adnexal lymphoma. J Clin Exp Hematop. 2010, 50:27-38. 10.3960\/jslrt.50.27","journal-title":"J Clin Exp Hematop"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.56.170","article-title":"Orbital MALT lymphoma after autologous stem cell transplantation for follicular lymphoma as relapse of diffuse large B-cell lymphoma","volume":"56","author":"Matsuo T","year":"2017","unstructured":"Matsuo T, Tanaka T, Fujii N. Orbital MALT lymphoma after autologous stem cell transplantation for follicular lymphoma as relapse of diffuse large B-cell lymphoma. J Clin Exp Hematop. 2017, 56:170-5. 10.3960\/jslrt.56.170","journal-title":"J Clin Exp Hematop"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.52.41","article-title":"Orbital MALT lymphoma, abdominal hodgkin lymphoma, and systemic diffuse large B-cell lymphoma develop sequentially in one patient","volume":"52","author":"Matsuo T","year":"2012","unstructured":"Matsuo T, Ichimura K, Shinagawa K. Orbital MALT lymphoma, abdominal hodgkin lymphoma, and systemic diffuse large B-cell lymphoma develop sequentially in one patient. J Clin Exp Hematop. 2012, 52:41-9. 10.3960\/jslrt.52.41","journal-title":"J Clin Exp Hematop"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.51.125","article-title":"Local recurrence as immunoglobulin G4 (IgG4)-related disease 10 years after radiotherapy to ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"51","author":"Matsuo T","year":"2011","unstructured":"Matsuo T, Ichimura K, Yoshino T. Local recurrence as immunoglobulin G4 (IgG4)-related disease 10 years after radiotherapy to ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. J Clin Exp Hematop. 2011, 51:125-33. 10.3960\/jslrt.51.125","journal-title":"J Clin Exp Hematop"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/23247096231185483","article-title":"Bilateral lacrimal gland mantle cell lymphoma in 11-year follow-up: Case report and review of 48 cases with ocular adnexal presentation in the literature","volume":"11","author":"Matsuo T","year":"2023","unstructured":"Matsuo T, Tanaka T, Okada K, Notohara K, Fujii K, Fujii N. Bilateral lacrimal gland mantle cell lymphoma in 11-year follow-up: Case report and review of 48 cases with ocular adnexal presentation in the literature. J Investig Med High Impact Case Rep. 2023, 11:10.1177\/23247096231185483","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/23247096211067894","article-title":"Diffuse Large B-Cell Lymphoma 18 Years After Bilateral Lacrimal Gland IgG4-Related Disease: Case Report and Literature Review","volume":"10","author":"Matsuo T","year":"2022","unstructured":"Matsuo T, Tanaka T, Notohara K, Okada K. Diffuse Large B-Cell Lymphoma 18 Years After Bilateral Lacrimal Gland IgG4-Related Disease: Case Report and Literature Review. J Investig Med High Impact Case Rep. 2022, 10:23247096211067894. 10.1177\/23247096211067894","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.48.17","article-title":"Different histopathological types of orbital lymphoma 16 years after systemic follicular lymphoma: immunohistochemical and immunogenetic analyses of two cases","volume":"48","author":"Matsuo T","year":"2008","unstructured":"Matsuo T, Ichimura K, Shinagawa K, Yoshino T. Different histopathological types of orbital lymphoma 16 years after systemic follicular lymphoma: immunohistochemical and immunogenetic analyses of two cases. J Clin Exp Hematop. 2008, 48:17-24. 10.3960\/jslrt.48.17","journal-title":"J Clin Exp Hematop"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.22015","article-title":"Diffuse large B-cell lymphoma in the course of systemic sarcoidosis: A case report and review of 30 Japanese patients with sarcoidosis-lymphoma syndrome","volume":"62","author":"Matsuo T","year":"2022","unstructured":"Matsuo T, Tanaka T, Omote R, Okada T, Notohara K, Okada K. Diffuse large B-cell lymphoma in the course of systemic sarcoidosis: A case report and review of 30 Japanese patients with sarcoidosis-lymphoma syndrome. J Clin Exp Hematop. 2022, 62:226-37. 10.3960\/jslrt.22015","journal-title":"J Clin Exp Hematop"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.50.129","article-title":"Immunoglobulin G4 (IgG4)-positive or -negative ocular adnexal benign lymphoid lesions in relation to systemic involvement","volume":"50","author":"Matsuo T","year":"2010","unstructured":"Matsuo T, Ichimura K, Sato Y, et al.. Immunoglobulin G4 (IgG4)-positive or -negative ocular adnexal benign lymphoid lesions in relation to systemic involvement. J Clin Exp Hematop. 2010, 50:129-42. 10.3960\/jslrt.50.129","journal-title":"J Clin Exp Hematop"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.20048","article-title":"Follow-up with serum IgG4-monitoring in 8 patients with IgG4-related disease diagnosed by a lacrimal gland mass","volume":"61","author":"Matsuo T","year":"2021","unstructured":"Matsuo T, Tanaka T, Sato Y, Kataoka H, Uka M, Ennishi D, Yano T. Follow-up with serum IgG4-monitoring in 8 patients with IgG4-related disease diagnosed by a lacrimal gland mass. J Clin Exp Hematop. 2021, 61:10-21. 10.3960\/jslrt.20048","journal-title":"J Clin Exp Hematop"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.17028","article-title":"Nephrotic syndrome during the tapering of oral steroids after pathological diagnosis of Kimura disease from a lacrimal gland mass: Case report and review of 10 Japanese patients","volume":"57","author":"Matsuo T","year":"2017","unstructured":"Matsuo T, Tanaka T, Kinomura M. Nephrotic syndrome during the tapering of oral steroids after pathological diagnosis of Kimura disease from a lacrimal gland mass: Case report and review of 10 Japanese patients. J Clin Exp Hematop. 2017, 57:147-52. 10.3960\/jslrt.17028","journal-title":"J Clin Exp Hematop"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-004-0095-6","article-title":"Systemic malignant lymphoma 17 years after bilateral orbital pseudotumor","volume":"48","author":"Matsuo T","year":"2004","unstructured":"Matsuo T, Sato Y, Kuroda R, Matsuo N, Yoshino T. Systemic malignant lymphoma 17 years after bilateral orbital pseudotumor. Jpn J Ophthalmol. 2004, 48:503-6. 10.1007\/s10384-004-0095-6","journal-title":"Jpn J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2014.376","article-title":"Ocular adnexal follicular lymphoma: A multicenter international study","volume":"132","author":"Rasmussen PK","year":"2014","unstructured":"Rasmussen PK, Coupland SE, Finger PT, et al.. Ocular adnexal follicular lymphoma: A multicenter international study. JAMA Ophthalmol. 2014, 132:851-8. 10.1001\/jamaophthalmol.2014.376","journal-title":"JAMA Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12525. Epub 2014 Aug 13","article-title":"Follicular lymphoma of the ocular adnexal region: A nation-based study","volume":"93","author":"Rasmussen PK","year":"2015","unstructured":"Rasmussen PK, Ralfkiaer E, Prause JU, et al.. Follicular lymphoma of the ocular adnexal region: A nation-based study. Acta Ophthalmol. 2015, 93:184-91. 10.1111\/aos.12525. Epub 2014 Aug 13","journal-title":"Acta Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(25)00034-1","article-title":"Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumor burden follicular lymphoma: Long-term results of a randomized, phase 3 trial","volume":"12","author":"Northend M","year":"2025","unstructured":"Northend M, Wilson W, Ediriwickrema K, et al.. Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumor burden follicular lymphoma: Long-term results of a randomized, phase 3 trial. Lancet Hematol. 2025, 12:335-45. 10.1016\/S2352-3026(25)00034-1","journal-title":"Lancet Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2022.10.001","article-title":"Radiation therapy for primary orbital and ocular adnexal lymphoma","volume":"38","author":"Pereira-Da Silva MV","year":"2023","unstructured":"Pereira-Da Silva MV, Di Nicola ML, Altomare F, Xu W, Tsang R, Laperriere N, Krema H. Radiation therapy for primary orbital and ocular adnexal lymphoma. Clin Transl Radiat Oncol. 2023, 38:15-20. 10.1016\/j.ctro.2022.10.001","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/895105","article-title":"Rituximab as single agent in primary MALT lymphoma of the ocular adnexa","volume":"2015","author":"Annibali O","year":"2015","unstructured":"Annibali O, Chiodi F, Sarlo C, et al.. Rituximab as single agent in primary MALT lymphoma of the ocular adnexa. Biomed Res Int. 2015, 2015:895105. 10.1155\/2015\/895105","journal-title":"Biomed Res Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.65","article-title":"Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma","volume":"4","author":"Mino T","year":"2014","unstructured":"Mino T, Mihara K, Yoshida T, Takihara Y, Ichinohe T. Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma. Blood Cancer J. 2014, 4:e245. 10.1038\/bcj.2014.65","journal-title":"Blood Cancer J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5237","article-title":"Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective study","volume":"12","author":"Mizuhara K","year":"2023","unstructured":"Mizuhara K, Kobayashi T, Nakao M, et al.. Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective study. Cancer Med. 2023, 12:3134-44. 10.1002\/cam4.5237","journal-title":"Cancer Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200106000-00004","article-title":"Cutaneous b-cell lymphomas of follicular and marginal zone types: Use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification","volume":"25","author":"de Leval L","year":"2001","unstructured":"de Leval L, Harris NL, Longtine J, Ferry JA, Duncan LM. Cutaneous b-cell lymphomas of follicular and marginal zone types: Use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification. Am J Surg Pathol. 2001, 25:732-41. 10.1097\/00000478-200106000-00004","journal-title":"Am J Surg Pathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/106689690501300110","article-title":"Follicular colonization of nodal marginal-zone B-cell lymphoma resembling follicular lymphoma: Report of 6 cases","volume":"13","author":"Kojima M","year":"2005","unstructured":"Kojima M, Nakamura S, Murase T, et al.. Follicular colonization of nodal marginal-zone B-cell lymphoma resembling follicular lymphoma: Report of 6 cases. Int J Surg Pathol. 2005, 13:73-8. 10.1177\/106689690501300110","journal-title":"Int J Surg Pathol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2007.02951.x","article-title":"Nodal marginal zone B-cell lymphoma with prominent follicular colonization - difficulties in diagnosis: a study of 15 cases","volume":"52","author":"Naresh KN","year":"2008","unstructured":"Naresh KN. Nodal marginal zone B-cell lymphoma with prominent follicular colonization - difficulties in diagnosis: a study of 15 cases. Histopathology. 2008, 52:331-9. 10.1111\/j.1365-2559.2007.02951.x","journal-title":"Histopathology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880284","article-title":"Follicular lymphoma with marginal zone differentiation: Microdissection demonstrates the t(14;18) in both the follicular and marginal zone components","volume":"14","author":"Yegappan S","year":"2001","unstructured":"Yegappan S, Schnitzer B, Hsi ED. Follicular lymphoma with marginal zone differentiation: Microdissection demonstrates the t(14;18) in both the follicular and marginal zone components. Mod Pathol. 2001, 14:191-6. 10.1038\/modpathol.3880284","journal-title":"Mod Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01580.x","article-title":"Follicular lymphoma with marginal zone differentiation: Cytogenetic findings in support of a high-risk variant of follicular lymphoma","volume":"42","author":"Goodlad JR","year":"2003","unstructured":"Goodlad JR, Batstone PJ, Hamilton D, Hollowood K. Follicular lymphoma with marginal zone differentiation: Cytogenetic findings in support of a high-risk variant of follicular lymphoma. Histopathology. 2003, 42:292-8. 10.1046\/j.1365-2559.2003.01580.x","journal-title":"Histopathology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i17.5877","article-title":"Follicular lymphoma presenting like marginal zone lymphoma: A case report","volume":"10","author":"Peng HY","year":"2022","unstructured":"Peng HY, Xiu YJ, Chen WH, Gu QL, Du X. Follicular lymphoma presenting like marginal zone lymphoma: A case report. World J Clin Cases. 2022, 10:5877-83. 10.12998\/wjcc.v10.i17.5877","journal-title":"World J Clin Cases"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018806","article-title":"Low-grade follicular lymphoma with extensive marginal zone differentiation and expression of MUM1 and CD30","volume":"141","author":"Baykara Y","year":"2023","unstructured":"Baykara Y, Kurt H. Low-grade follicular lymphoma with extensive marginal zone differentiation and expression of MUM1 and CD30. Blood. 2023, 141:1363. 10.1182\/blood.2022018806","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2014-0058-RA","article-title":"New immunohistochemistry for B-cell lymphoma and Hodgkin lymphoma","volume":"138","author":"Zhang XM","year":"2014","unstructured":"Zhang XM, Aguilera N. New immunohistochemistry for B-cell lymphoma and Hodgkin lymphoma. Arch Pathol Lab Med. 2014, 138:1666-72. 10.5858\/arpa.2014-0058-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12392","article-title":"Duodenal follicular lymphoma: Comprehensive gene expression analysis with insights into pathogenesis","volume":"105","author":"Takata K","year":"2014","unstructured":"Takata K, Tanino M, Ennishi D, et al.. Duodenal follicular lymphoma: Comprehensive gene expression analysis with insights into pathogenesis. Cancer Sci. 2014, 105:608-15. 10.1111\/cas.12392","journal-title":"Cancer Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.18926\/AMO\/53676","article-title":"Primary duodenal follicular lymphoma treated with rituximab monotherapy and followed-up for 15 years","volume":"69","author":"Seki A","year":"2015","unstructured":"Seki A, Iwamuro M, Yoshioka M, et al.. Primary duodenal follicular lymphoma treated with rituximab monotherapy and followed-up for 15 years. Acta Med Okayama. 2015, 69:301-6. 10.18926\/AMO\/53676","journal-title":"Acta Med Okayama"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/386735-six-year-remission-with-no-relapse-after-four-time-weekly-rituximab-only-for-bilateral-ocular-adnexal-follicular-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T05:53:26Z","timestamp":1753768406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/386735-six-year-remission-with-no-relapse-after-four-time-weekly-rituximab-only-for-bilateral-ocular-adnexal-follicular-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.88945","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}